⌕
Bioventus · BVS · Nasdaq
Tenet 56 · Mixed
Compare
$10.60+1.34%At closeTenet 56 · Mixed
$10.60+0.14 (+1.34%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Bioventus (BVS) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is BVS's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● Seeking AlphaNov 3, 2026 · 01:28 ET
Bioventus Inc. (BVS) Q3 2026 Earnings Call Transcript

Bioventus Inc. ( BVS ) Q3 2026 Earnings Call November 2, 2026 4:30 PM EST Company Participants David Crawford - Vice President of Investor Relations & Treasurer Robert Claypoole - President, CEO & Director Mark Singleton…

BVS +1.3% todayRead at source ↗
● Zacks Investment ResearchNov 2, 2026 · 18:56 ET
Bioventus (BVS) Matches Q3 Earnings Estimates

Bioventus (BVS) came out with quarterly earnings of $0.17 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.15 per share a year ago.…

BVS +1.3% todayRead at source ↗
● MarketBeatNov 2, 2026 · 18:14 ET
Bioventus Q3 Earnings Call Highlights

Bioventus NASDAQ: BVS reported third-quarter revenue growth of 3% as strength in its Pain Treatments business, Ultrasonics operation and international markets was partly offset by softness in bone graft substitutes, or B…

BVS +1.3% todayRead at source ↗
● GlobeNewsWireNov 2, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Bioventus Reports Third Quarter Financial Results

DURHAM, N.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today reported financial results for the three and nine mont…

BVS +1.3% todayRead at source ↗
● GlobeNewsWireOct 27, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026

DURHAM, N.C., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for th…

BVS +1.3% todayRead at source ↗
● GuruFocusOct 12, 2026 · 20:01 ET
Bioventus Inc (BVS) Stock Up 3.6% but GF Value Says Overvalued -- GF Score: 63/100

On October 12, 2026, Bioventus Inc (BVS) shares rose 3.6% today, currently priced at $13.53. This move comes amid a 52-week range of $6.46 to $15.89.GF Value™…

BVS +1.3% todayRead at source ↗
● Defense WorldOct 12, 2026 · 01:44 ET
Comparing Kestra Medical Technologies (NASDAQ:KMTS) & Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ: BVS - Get Free Report) and Kestra Medical Technologies (NASDAQ: KMTS - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies base…

BVS +1.3% todayRead at source ↗
● Defense WorldOct 6, 2026 · 03:30 ET
Reviewing Bioventus (NASDAQ:BVS) & RxSight (NASDAQ:RXST)

RxSight (NASDAQ: RXST - Get Free Report) and Bioventus (NASDAQ: BVS - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength…

BVS +1.3% todayRead at source ↗
● Seeking AlphaSep 21, 2026 · 02:34 ET
Bioventus: Cash Flow Anchors The Bull Case Beyond A Potential Sale

Bioventus leverages cash from established products to reduce debt and fund commercial expansion, supporting a bullish outlook. BVS benefits from improved financing flexibility, with a term loan maturity extended to 2030 …

BVS +1.3% todayRead at source ↗
● Zacks Investment ResearchAug 24, 2026 · 10:40 ET
Are Medical Stocks Lagging Bioventus (BVS) This Year?

Here is how Bioventus (BVS) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.…

BVS +1.3% todayRead at source ↗
● Zacks Investment ResearchAug 20, 2026 · 09:51 ET
4 Healthcare Stocks to Safeguard Your Portfolio as Fed Plans Rate Hike

A rate hike could keep markets volatile, making BVS, CNC, AMRX and CRON healthcare stocks to consider as inflation stays elevated.…

BVS +1.3% todayRead at source ↗

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

NVDA29−0.4%
WDAY4−5.8%
BBW3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just BVS · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.